共 120 条
[1]
Colton CW(2006)Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states Prevent Chronic Dis. 3 A42-93
[2]
Manderscheid RW(2008)Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis BMC Psychiatry. 8 84-602
[3]
Osborn DP(2005)Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review CNS Drugs. 19 1-24
[4]
Wright CA(2009)Identifying clinically questionable psychotropic prescribing practices for Medicaid recipients in New York state Psychiatr Serv. 60 1595-9
[5]
Levy G(2010)Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs Arch Gen Psychiatry. 67 17-4
[6]
King MB(2015)Diabetes Screening Among Underserved Adults With Severe Mental Illness Who Take Antipsychotic Medications JAMA Internal Med. 175 1977-37
[7]
Deo R(2007)Improving medical care for persons with serious mental illness: challenges and solutions J Clin Psychiatry. 68 40-514
[8]
Nazareth I(2014)Using electronic health records to improve the physical healthcare of people with serious mental illnesses: a view from the front lines Int Rev Psychiatry. 26 629-11
[9]
Newcomer JW(2008)Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage Health Serv Res. 43 496-301
[10]
Essock SM(2000)Mental disorders and use of cardiovascular procedures after myocardial infarction Jama. 283 506-16